Influenza Vaccines Global Market Opportunities And Strategies To 2033

Description

Influenza vaccines are biological preparations designed to provide immunity against the influenza virus, commonly known as the flu. These vaccines are primarily utilized by individuals across various age groups, including children, adults and the elderly, to prevent seasonal influenza infections.

The influenza vaccines market consists of sales, by entities (organizations, sole traders or partnerships), of vaccines designed to protect against the seasonal influenza virus. These vaccines work by stimulating the immune system to produce antibodies that can recognize and fight off the virus. They are designed to protect against the most prevalent strains of the virus, which are updated annually based on predictions of circulating flu strains, making them a critical tool in preventing seasonal outbreaks and reducing the severity of symptoms in those who contract the virus.

The global influenza vaccines market was valued at $5,847.70 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Expansion Of Vaccination Programs

Expansion of vaccination programs drove the growth of the influenza vaccine market during this historic period. Vaccination refers to the process of administering a vaccine to help the body develop immunity against a specific infectious disease. The expansion of vaccination programs are driven by their effectiveness in preventing the spread of infectious diseases, reducing healthcare costs and protecting vulnerable populations from serious illness and complications. The influenza vaccine plays a key role in the expansion of vaccination by providing a widely accessible and effective means of preventing seasonal flu outbreaks, helping to reduce illness, hospitalizations and the burden on healthcare systems. For instance, in October 2024, according to a report published by the European Commission, a European-based governing body, the European Commission has secured up to 4.2 billion doses of COVID-19 vaccines and as of August 2023, 84.8% of the EU adult population has been vaccinated at least once. Therefore, expansion of vaccination programs contributed to the growth of the influenza vaccine market.

Technological Advancement To Drive Innovation In The Influenza Vaccine

Major companies in the influenza vaccine market are leveraging technological advancements, such as the development of advanced Quadrivalent Influenza vaccines, to gain a competitive edge. These vaccines are designed to protect against four different influenza virus strains. For example, in March 2024, Cadila Pharmaceuticals Limited, an Indian pharmaceutical company, launched the Cadiflu Tetra Vaccine. This innovative product aims to significantly reduce the incidence of influenza, lessen the severity of the illness and curb the transmission of the virus. The Cadiflu Tetra Vaccine offers unique features, including quadrivalent protection, an enhanced immune response through its advanced formulation and a focus on improving community health by reducing virus transmission.

Sanofi SA was the largest competitor with a 36.60% share of the market, followed by Seqirus (CSL Limited) and GlaxoSmithKline Plc

Influenza Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global influenza vaccines market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for influenza vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza vaccines market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider influenza vaccines market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by vaccine type, by valency, by route of administration, by age group and by distribution channel.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the influenza vaccines market.

Global Market Size And Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by vaccine type, by valency, by route of administration, by age group and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for influenza vaccines providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Vaccine: Inactivated; Live Attenuated; Recombinant
2) By Valency: Quadrivalent; Trivalent
3) By Route Of Administration: Injection; Nasal Spray
4) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels
5) By Age Group: Pediatric; Adult
Companies Mentioned: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza vaccines indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1454

1 Executive Summary

1.1 Influenza Vaccines - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Influenza Vaccines Market Definition And Segmentations
6.4 Market Segmentation By Vaccine Type
- 6.4.1 Inactivated
- 6.4.2 Live Attenuated
- 6.4.3 Recombinant
6.5 Market Segmentation By Valency
- 6.5.1 Quadrivalent
- 6.5.2 Trivalent
6.6 Market Segmentation By Route Of Administration
- 6.6.1 Injection
- 6.6.2 Nasal Spray
6.7 Market Segmentation By Age Group
- 6.7.1 Pediatric
- 6.7.2 Adult
6.8 Market Segmentation By Distribution Channel
- 6.8.1 Hospitals And Pharmacies
- 6.8.2 Government And Institutional Supply
- 6.8.3 Other Distribution Channels

7 Major Market Trends

7.1 Technological Advancement To Drive Innovation In The Influenza Vaccine
7.2 Expansion Of Influenza Vaccine Production Capacity
7.3 Advancements In Influenza Vaccine Development
7.4 Strategic Partnerships And Collaborations Among Market Players

8 Influenza Vaccines Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Influenza Vaccines Market
8.2 Impact Of The War In Ukraine On The Influenza Vaccines Market
8.3 Impact Of High Inflation On The Influenza Vaccines Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Influenza Vaccines Market Segmentation

10.1 Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Influenza Vaccines Market, Segmentation By Age Group, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.5 Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Influenza Vaccines Market, Regional and Country Analysis

11.1 Global Influenza Vaccines Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Influenza Vaccines Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia Pacific Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia Pacific Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Influenza Vaccines Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate tax structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.2 Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Influenza Vaccines Market: Country Analysis
13.6 UK Market
13.7 UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Major companies
14.2 Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Influenza Vaccines Market: Country Analysis
14.6 Russia Market
14.7 Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Influenza Vaccines Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Influenza Vaccines Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Major Companies
17.2 Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.2.1 Market Overview
- 18.2.2 Region Information
- 18.2.3 Market Information
- 18.2.4 Background Information
- 18.2.5 Government Initiatives
- 18.2.6 Regulations
- 18.2.7 Regulatory Bodies
- 18.2.8 Major Associations
- 18.2.9 Taxes Levied
- 18.2.10 Corporate Tax Structure
- 18.2.11 Investments
- 18.2.12 Major Companies
18.3 Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 Sanofi S.A.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 Seqirus (CSL Limited)
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 GlaxoSmithKline plc
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Daiichi Sankyo Co. Ltd
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Pfizer Inc
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview

20 Other Major And Innovative Companies

20.1 Abbott Laboratories
- 20.1.1 Company Overview
- 20.1.2 Products and Services
20.2 AstraZeneca Plc
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 Sinovac Biotech Ltd
- 20.3.1 Company Overview
- 20.3.2 Products And Services
20.4 Serum Institute of India
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 BioDiem Ltd
- 20.5.1 Company Overview
- 20.5.2 Products and Services
20.6 Takeda Pharmaceutical Company Limited
- 20.6.1 Company Overview
- 20.6.2 Products and Services
20.7 EMERGENT BIOSOLUTIONS INC
- 20.7.1 Company Overview
- 20.7.2 Products and Services
20.8 BiondVax Pharmaceuticals Ltd
- 20.8.1 Company Overview
- 20.8.2 Products and Services
20.9 Gamma Vaccines Pty Ltd
- 20.9.1 Company Overview
- 20.9.2 Products and Services
20.10 Osivax
- 20.10.1 Company Overview
- 20.10.2 Products and Services
20.11 Vaxart Inc
- 20.11.1 Company Overview
- 20.11.2 Products and Services
20.12 Vaxess Technologies Inc
- 20.12.1 Company Overview
- 20.12.2 Products and Services
20.13 Biken Techno Corp
- 20.13.1 Company Overview
- 20.13.2 Products and Services
20.14 Johnson & Johnson
- 20.14.1 Company Overview
- 20.14.2 Products and Services
20.15 Flugen Inc
- 20.15.1 Company Overview
- 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 GSK Acquired CureVac
23.2 AstraZeneca Acquired Icosavax
23.3 GSK Acquired Affinivax

24 Opportunities And Strategies

24.1 Global Influenza Vaccines Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Influenza Vaccines Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Influenza Vaccines Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Influenza Vaccines Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer